Brief: IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
29/10/2025 12:59
Oct 29 (Reuters) - IN8bio Inc INAB.O: IN8BIO EXPANDS INB-100 PHASE 1 CLINICAL TRIAL WITH ADDITION OF THE OHIO STATE UNIVERSITY AS NEW SITE Source text: ID:nGNX7bsP5Q Further company coverage: INAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall